Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Mclaughlin

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
International Journal of Genomics and Data Mining|September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARSKenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Journal of the Neurological Sciences|September 29, 2023
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatryKenneth Blum, J Wesson Ashford, Babak Kateb, et al.
Journal of Addiction Psychiatry|January 2, 2024
Are We Getting High Cause the Thrill is Gone?Kenneth Blum, Thomas Mclaughlin, Mark S Gold, et al.
Nature Methods|May 24, 2011
High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arraysVéronique Lecault, Michael Vaninsberghe, Sanja Sekulovic, et al.
BMC Genomics|September 21, 2004
PEDRo: a database for storing, searching and disseminating experimental proteomics dataKevin Garwood, Thomas McLaughlin, Chris Garwood, et al.
MMWR. Morbidity and Mortality Weekly Report|May 23, 2014
Rabies death attributed to exposure in Central America with symptom onset in a U.S. detention facility - Texas, 2013Ryan M Wallace, Darlene Bhavnani, John Russell, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Medical Research Archives|October 27, 2023
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine HomeostatsisKenneth Blum, Mark S Gold, Jean Lud Cadet, et al.
Gene & Protein in Disease|May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequencesKenneth Blum, Abdalla Bowirrat, David Baron, et al.
Journal of Addiction Psychiatry|December 5, 2024
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration TherapyFoojan Zeine, Nicole Jafari, David Baron, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Genomics and Data Mining|September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARSKenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Journal of the Neurological Sciences|September 29, 2023
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatryKenneth Blum, J Wesson Ashford, Babak Kateb, et al.
Journal of Addiction Psychiatry|January 2, 2024
Are We Getting High Cause the Thrill is Gone?Kenneth Blum, Thomas Mclaughlin, Mark S Gold, et al.
Nature Methods|May 24, 2011
High-throughput analysis of single hematopoietic stem cell proliferation in microfluidic cell culture arraysVéronique Lecault, Michael Vaninsberghe, Sanja Sekulovic, et al.
BMC Genomics|September 21, 2004
PEDRo: a database for storing, searching and disseminating experimental proteomics dataKevin Garwood, Thomas McLaughlin, Chris Garwood, et al.
MMWR. Morbidity and Mortality Weekly Report|May 23, 2014
Rabies death attributed to exposure in Central America with symptom onset in a U.S. detention facility - Texas, 2013Ryan M Wallace, Darlene Bhavnani, John Russell, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Medical Research Archives|October 27, 2023
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine HomeostatsisKenneth Blum, Mark S Gold, Jean Lud Cadet, et al.
Gene & Protein in Disease|May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequencesKenneth Blum, Abdalla Bowirrat, David Baron, et al.
Journal of Addiction Psychiatry|December 5, 2024
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration TherapyFoojan Zeine, Nicole Jafari, David Baron, et al.
Pageof 7